Full history for every metric is available with a Kvantra account

Stock profile

Hologic, Inc. (HOLX)

Country: United States of AmericaSector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: NASDAQ

Delisted · last close 7 Apr 2026

Current price
76.01 USD0.00%
Last close 7 Apr 2026
Benchmarks

Key financial summary

Financials in USD
202020212022202320242025TTM
Total revenue$m3,7765,6324,8634,0304,0304,1014,126
Operating profit$m714722
Net profit$m1,1151,8721,302456790566544
EPS reported$2.492.40
Operating cashflow per share$4.654.14
Capex per share$0.600.26
FCF per share$4.053.88
Free cash flow$m9201,000
Net debt$m305144
Book value equity$m5,0485,245
Book value per share$22.1823.22
Number of sharesm227.57225.88
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
202020212022202320242025TTM
Value
P/E TTMx26.9931.67
P/B LTMx3.023.24
P/S LTMx3.724.11
P/FCF LTMx16.6016.98
EV/EBITDA LTMx15.5716.88
EV/Sales LTMx3.894.15
Earnings Yield LTM%3.71%3.16%
FCF Yield%6.03%5.89%
Quality
ROE%11.21%11.13%
ROIC%7.35%7.17%
Operating margin%17.42%23.34%
Gross margin%61.00%57.74%
FCF/Sales%22.44%27.89%
Growth and momentum
EPS Growth YoY%-25.00%-24.29%
Sales Growth YoY%+1.74%+2.16%
Net Income Growth YoY%-28.35%-26.90%
FCF Growth%-19.64%-9.56%
Operating Profit Growth%-19.07%-23.81%
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx0.350.40
Net Debt/EBITDAx0.650.38
EBIT/Net interestx16.7311.02
Net debt/market cap%2.00%0.85%
Net debt/Equityx0.060.03
Gross debt/equityx0.520.48

Company overview

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

WebsiteN/A
IndustryMedical - Instruments & Supplies
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 7 Apr 2026

Hologic, Inc. (HOLX)

HOLX · NASDAQ · Healthcare
76.01 USD0.00%
Benchmarks
Financialsin USD
20242025TTM
About

Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.

IndustryMedical - Instruments & Supplies
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free